Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profileg
Emmanuel Ekanem

@E_EkanemMD

Cardiac Electrophysiologist, Winchester Medical Center, Family First, opinions are my own

ID:1231208198541127681

calendar_today22-02-2020 13:24:56

49 Tweets

230 Followers

54 Following

Follow People
Virtual EP Connect(@ConnectEp) 's Twitter Profile Photo

Join us this Friday starting @ 12pm for @connectEP Session LXII: Pulsed Field Ablation for Atrial Fibrillation: ADVENT & MANIFEST 10K+ featuring Vivek Y. Reddy Emmanuel Ekanem Moussa Mansour David Haines, Pierre Jaïs, Francis Marchlinski. Register @ epconnect.live/PFAsession

#EPeeps Join us this Friday starting @ 12pm for @connectEP Session LXII: Pulsed Field Ablation for Atrial Fibrillation: ADVENT & MANIFEST 10K+ featuring @VivekReddyMD @E_EkanemMD @MoussaMansour10 David Haines, Pierre Jaïs, Francis Marchlinski. Register @ epconnect.live/PFAsession
account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

MANIFEST-17K study is the largest registry of PFA to date: 17,642 pts/ 106 sites.
-Major complication rate of 1%- No AE fistula/PV stenosis
-Coronary spasms were rare but can be associated with VF
-Previously unreported AE-Hemolysis with renal failure (0.03%)

MANIFEST-17K study is the largest registry of PFA to date: 17,642 pts/ 106 sites. -Major complication rate of 1%- No AE fistula/PV stenosis -Coronary spasms were rare but can be associated with VF -Previously unreported AE-Hemolysis with renal failure (0.03%)
account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

Our study, MANIFEST-17K, will be presented this morning at as a Featured Science Abstract! Assessed the safety of post approval PFA with a pentaspline catheter in treating >17, 000 pts with AF.
Stay tuned for the results.
-17kConsortium
Vivek Y. Reddy AHA Science

Our study, MANIFEST-17K, will be presented this morning at #AHA23 as a Featured Science Abstract! Assessed the safety of post approval PFA with a pentaspline catheter in treating >17, 000 pts with AF. Stay tuned for the results. #MANIFEST-17kConsortium @VivekReddyMD @AHAScience
account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

After a few months with the Biosense Webster QDOT ablation catheter.. thus far a great addition to the therapeutic armamentarium

-🤔 “super” high power (90 watts) -catheter-tissue interface heat map
-modulated catheter tip irrigation

Pretty cool tech!

Mount Sinai Fuster Heart Hospital

account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

122 electrodes on a 33 mm spherical array> mapping/pacing/PFA from customizable ablation elements around the “globe”.
First series of patients in the US as part of the PULSAR clinical study which aims to enroll >400 patients world wide.
Vivek Y. Reddy @mohitkturagam Kardium

account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

122 electrodes on a 33 mm spherical array> mapping/pacing/PFA from customizable ablation elements around the “globe”.
First series of patients in the US as part of the PULSAR clinical study which aims to enroll >400 patients world wide.
Vivek Y. Reddy @mohitkturagam Kardium

account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

..And we are off! First case in the AdvantageAF study-A Prospective Single Arm Study of the @farapulse PFA System in pts with persistent AF. Goal to enroll ~417 pts. Look forward to the results and impact on the management of AF. Vivek Y. Reddy @mohitkturagam BostonSci Cardiology

..And we are off! First case in the AdvantageAF study-A Prospective Single Arm Study of the @farapulse PFA System in pts with persistent AF. Goal to enroll ~417 pts. Look forward to the results and impact on the management of AF. @VivekReddyMD @mohitkturagam @BSCCardiology
account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

The 2023 Atrial Fibrillation Symposium was truly a fantastic conference! Late breaking clinical trials, ground breaking advances, second generation PFA! I commend the organizers for a great conference!

account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

Our follow up study was recently presented as late breaking trial at ESC 2022. MANIFEST-PF study is the largest real world registry evaluating the safety and clinical efficacy of PFA! European Society of Cardiology Vivek Y. Reddy @mohitkturagam Andreas Metzner Serge Boveda Thomas Deneke Roland Tilz

Our follow up study was recently presented as late breaking trial at ESC 2022. MANIFEST-PF study is the largest real world registry evaluating the safety and clinical efficacy of PFA! @escardio @VivekReddyMD @mohitkturagam @AndreasMetzner7 @SergeBoveda @EPDeneke @RolandTilz
account_circle
BostonSci Cardiology(@BSCCardiology) 's Twitter Profile Photo

Real-world use of the FARAPULSE™ PFA System (MANIFEST-PF): Retrospective multi-national survey of over 1700 patients. See the publication here: bit.ly/3zDZ50l

Caution: Investigational Device. Limited by US law to investigational use only. Not available for sale.

account_circle
Christopher O'Connor(@coconnormd) 's Twitter Profile Photo

A privilege to recognize the Cardiology Fellows at their graduation dinner . Hooman to Hopkins ( Interventional), Lenny to Tufts (HF), Emanuel returns from Sinai (EP) to share the value of Inova training. Congrats to all faculty and fellows . Well done !

A privilege to recognize the Cardiology Fellows at their graduation dinner . Hooman to Hopkins ( Interventional), Lenny to Tufts (HF), Emanuel returns from Sinai (EP) to share the value of Inova training. Congrats to all faculty and fellows . Well done !
account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

Our study, MANIFEST-PF recent late breaking at EHRA, is now available in this issue of Europace! Largest (n=1758 pts) real world registry of PFA! doi.org/10.1093/europa… Vivek Y. Reddy @mohitkturagam Andreas Metzner Philipp Sommer Serge Boveda Thomas Deneke Roland Tilz

account_circle
David Power(@rowpower) 's Twitter Profile Photo

Our work on interatrial block just presented at by Joshua Lampert, MD

We studied 1,068,694 patients across 5 centers examining IAB outcomes (in AF and non-AF👥)

🔑finding
IAB associated with a 49% increased adj risk of stroke in patients without AFib

Ben Glicksberg lab

Our work on interatrial block just presented at #HRS2022 by @joshualampertmd We studied 1,068,694 patients across 5 centers examining IAB outcomes (in AF and non-AF👥) 🔑finding IAB associated with a 49% increased adj risk of stroke in patients without AFib @BenGlicksberg lab
account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

Great experience participating in live case today demonstrating VoM infusion strategy for persistent AF ablation. Previously shown to improve freedom from AF/AT/AFL and acute success and durability of mitral block. Vivek Y. Reddy @mohitkturagam Mount Sinai Fuster Heart Hospital

Great experience participating in live case today demonstrating VoM infusion strategy for persistent AF ablation. Previously shown to improve freedom from AF/AT/AFL and acute success and durability of mitral block. #AFSymposium2022 @VivekReddyMD @mohitkturagam @MountSinaiHeart
account_circle
Emmanuel Ekanem(@E_EkanemMD) 's Twitter Profile Photo

Excellent talks and innovative research and technology is on display during the ongoing Vivek Y. Reddy Moussa Mansour Looking forward to participating in live case today @ 11pm! Tune in!

Excellent talks and innovative research and technology is on display during the ongoing #AFsymposium @VivekReddyMD @MoussaMansour10 Looking forward to participating in live case today @ 11pm! Tune in!
account_circle